Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-8448b6f56d-m8qmq Total loading time: 0 Render date: 2024-04-20T04:10:57.725Z Has data issue: false hasContentIssue false

Chapter 18 - Results of Conservative Management of Ovarian Malignant Tumors

from Section 5 - Fertility Preservation Strategies in the Female: Medical/Surgical

Published online by Cambridge University Press:  27 March 2021

By
Catherine Uzan ,
Nathalie Chabbert-Buffet ,
Blandine Courbiere ,
Sebastien Gouy  and
Philippe Morice
Edited by
Jacques Donnez  and
S. Samuel Kim
Jacques Donnez
Affiliation:
Catholic University of Louvain, Brussels
S. Samuel Kim
Affiliation:
University of Kansas School of Medicine
Get access

Summary

Although cancer usually affects aged population, invasive gynecological tumors can occur during reproductive age. Long-term survival rates after gynecological cancer are improving and preservation of fertility has logically become a major issue.

In gynecologic oncologic surgery, there has been gradual development of fertility-saving surgery (FSS) with the aim of preserving the reproductive organs. Survival should not be compromised and thus indications are restricted to patients of a young age with a desire to preserve fertility and presenting with a well-differentiated cervical, ovarian, or endometrial low-grade tumor in its early stages or with low malignant potential.

In this chapter, we discuss indications for FSS in women with gynecological cancer, according to oncological and reproductive outcomes.

Type
Chapter
Information
Fertility Preservation
Principles and Practice
 , pp. 197 - 210
Publisher: Cambridge University Press
Print publication year: 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Taylor, HC. Malignant and semi-malignant tumors of the ovary. Surg Gynecol Obstet, 1929;48:204–230.Google Scholar
Hart, WR, Norris, HJ. Borderline and malignant mucinous tumors of the ovary. Cancer, 1973;31:1031–1044.Google Scholar
Bell, DA, Weinstock, MA, Scully, RE. Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis. Cancer, 1988;62:2212–2222.Google Scholar
Duvillard, P. Tumeurs ovariennes à la limite de la malignité. Ann. Pathol, 1996;16:396–405.Google Scholar
Gershenson, D, Silva, E, Levy, L et al. Ovarian serous borderline tumors with invasive peritoneal implants. Cancer, 1998;82:1096–1103.3.0.CO;2-1>CrossRefGoogle ScholarPubMed
Gershenson, D, Silva, EL, Tortolero-Luna, G et al. Serous borderline tumors of the ovary with non invasive peritoneal implants. Cancer, 1998;83:2157–2163.3.0.CO;2-D>CrossRefGoogle Scholar
Seidman, JD, Kurman, RJ. Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases. Am J Surg Pathol, 1996;20:1331–1345.CrossRefGoogle ScholarPubMed
Kane, A, Uzan, C, Rey, A, Gouy, S et al. Prognostic factors in patients with ovarian serous low malignant potential (borderline) tumors with peritoneal implants. Oncologist, 2009;14:591–600.CrossRefGoogle ScholarPubMed
Seidman, JD, Kurman, RJ. Treatment of micropapillary serous ovarian carcinoma (the aggressive variant of serous borderline tumors. Cancer, 2002;95:675–676.Google Scholar
Eichhorn, JH, Bell, DA, Young, RH et al. Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns. Am J Surg Pathol, 1999;23:397–409.Google Scholar
Morice, P, Uzan, C, Fauvet, R et al. Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence. Lancet Oncol, 2012 March;13(3):e103–e115.CrossRefGoogle ScholarPubMed
Trimble, CL, Kosary, C, Trimble, EL. Long-term and patterns of care in women with ovarian tumors of low malignant potential. Gynecol Oncol, 2002;86:34–37.Google Scholar
Daraï, E, Fauvet, R, Uzan, C et al. Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options. Hum Reprod Update, 2013 March–April;19(2):151–166.CrossRefGoogle ScholarPubMed
Palomba, S, Zupi, E, Russo, T et al. Comparison of two fertility-sparing approaches for bilateral borderline ovarian tumours: a randomized controlled study. Hum Reprod, 2007;22:578–585.CrossRefGoogle ScholarPubMed
Palomba, S, Falbo, A, Del Negro, S et al. Ultra-conservative fertility-sparing strategy for bilateral borderline ovarian tumours: an 11-year follow-up. Hum Reprod, 2010;25:1966–1972.CrossRefGoogle Scholar
Bendifallah, S, Ballester, M, Uzan, C et al. Nomogram to predict recurrence in patients with early and advanced-stage mucinous and serous borderline ovarian tumors. Am J Obstet Gynecol, 2014 December;211(6):637.e1–6.Google Scholar
Morice, P, Uzan, C, Fauvet, R et al. Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence. Lancet Oncol, 2012 March;13(3):e103–e115.Google Scholar
Uzan, C, Nikpayam, M, Ribassin-Majed, L et al. Influence of histological subtypes on the risk of an invasive recurrence in a large series of stage I borderline ovarian tumor including 191 conservative treatments. Ann Oncol, 2014 July;25(7):1312–1319.Google Scholar
du Bois, A, Ewald-Riegler, N, de Gregorio, N et al.; Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group. Borderline tumours of the ovary: A cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group. Eur J Cancer, 2013 May;49(8):1905–1914.CrossRefGoogle Scholar
Fauvet, R, Poncelet, C, Boccara, J et al. Fertility after conservative treatment for borderline ovarian tumors: a French multicenter study. Fertil Steril, 2005;83:284–290, quiz 525–286.CrossRefGoogle ScholarPubMed
Kanat-Pektas, M, Ozat, M, Gungor, T et al. Fertility outcome after conservative surgery for borderline ovarian tumors: a single center experience. Arch Gynecol Obstet, 2011;284:1253–1258.Google Scholar
Trillsch, F, Mahner, S, Woelber, L et al. Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study. Ann Oncol, 2014 July;25(7):1320–1327.Google Scholar
Fauvet, R, Demblocque, E, Morice, P, Querleu, D, Darai, E. Behavior of serous borderline ovarian tumors with and without micropapillary patterns: results of a French multicenter study. Ann Surg Oncol, 2012;19:941–947.CrossRefGoogle ScholarPubMed
Ouldamer, L, Bendifallah, S, Naoura, I et al. Nomogram to predict live birth rate after fertility-sparing surgery for borderline ovarian tumours. Hum Reprod, 2016 August;31(8):1732–1737.CrossRefGoogle ScholarPubMed
Rizzuto, I1, Behrens, RF, Smith, LA. Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility. Cochrane Database Syst Rev, 2013 August;13(8):CD008215.Google Scholar
Basille, C, Olivennes, F, Le Calvez, J et al. Impact of gonadotrophins and steroid hormones on tumour cells derived from borderline ovarian tumours. Hum Reprod, 2006;21:3241–3245.Google Scholar
Nijman, HW, Burger, CW, Baak, JP et al. Borderline malignancy of the ovary and controlled hyperstimulation, a report of 2 cases. Eur J Cancer, 1992;28A:1971–1972.Google Scholar
Mantzavinos, T, Kanakas, N, Genatas, C et al. Five years’ follow-up in two patients with borderline tumors of the ovary hyperstimulated by gonadotrophin therapy for in-vitro fertilization. Hum Reprod, 1994;9:2032–2033.Google Scholar
Lawal, AH, Lynch, CB. Borderline ovarian cancer, bilateral surgical castration, chemotherapy and a normal delivery after ovum donation and in vitro fertilisation-embryo transfer. Br J Obstet Gynaecol, 1996;103:931–932.CrossRefGoogle Scholar
Hoffman, JS, Laird, L, Benadiva, C et al. In vitro fertilization following conservative management of stage 3 serous borderline tumor of the ovary. Gynecol Oncol, 1999;74:515–518.Google Scholar
Gallot, D, Pouly, JL, Janny, L et al. Successful transfer of frozen-thawed embryos obtained immediately before radical surgery for a stage IIIa serus borderline ovarian tumor: Case report. Hum Reprod, 2000;15:2347–2350.Google Scholar
Morris, RT, Gershenson, DM, Silva, EG et al. Outcome and reproductive function after conservative surgery for borderline ovarian tumors. Obstet Gynecol, 2000;95:541–547.Google Scholar
Beiner, ME, Gotlieb, WH, Davidson, B et al. Infertility treatment after conservative management of borderline ovarian tumors. Cancer, 2001;92:320–325.Google Scholar
Attar, E, Berkman, S, Topuz, S et al. Evolutive peritoneal disease after conservative management and the use of infertility drugs in a patient with stage IIIC borderline micro-papillary serous carcinoma (MPSC) of the ovary: case report. Hum Reprod, 2004;19:1472–1475.CrossRefGoogle Scholar
Fasouliotis, SJ, Davis, O, Schattman, G et al. Safety and efficacy of infertility treatment after conservative management of borderline ovarian tumors: a preliminary report. Fertil Steri, 2004;82:568–572.Google Scholar
Marcickiewicz, J, Brannstrom, M. Fertility preserving surgical treatment of borderline ovarian tumour: long-term consequence for fertility and recurrence. Acta Obtet Gynecol Scand, 2006;85:1496–1500.Google Scholar
Fortin, A, Morice, P, Thoury, A et al. Impact of infertility drugs after treatment of borderline ovarian tumors: results of a retrospective multicenter study. Fertil Steril, 2007;87:591–596.CrossRefGoogle ScholarPubMed
Park, CW, Yang, KM, Kim, HO et al. Outcomes of controlled ovarian hyperstimulation/in vitro fertilization for infertile patients with borderline ovarian tumor after conservative treatment. J Korean Med Sci, 2007;22 Suppl:S134–S138.CrossRefGoogle ScholarPubMed
Yinon, Y, Beiner, ME, Gotlieb, WH et al. Clinical outcome of cystectomy compared with unilateral salpingo-oophorectomy as fertility-sparing treatment of borderline ovarian tumors. Fertil Steril, 2007;88:479–484.CrossRefGoogle ScholarPubMed
Porcu, E, Venturoli, S, Damiano, G et al. Healthy twins delivered after oocyte cryopreservation and bilateral ovariectomy for ovarian cancer. Reprod Biomed Online, 2008;17:265–267.Google Scholar
Cabenda-Narain, NE, Jansen, FW, Dieben, SW, Verburg, HJ, Gaarenstroom, KN. Conservatively treated borderline ovarian tumours, followed by IVF treatment: a case series. J Obstet Gynaecol, 2011;31:327–329.CrossRefGoogle ScholarPubMed
Koskas, M, Uzan, C, Gouy, S et al. Fertility determinants after conservative surgery for mucinous borderline tumours of the ovary (excluding peritoneal pseudomyxoma). Hum Reprod, 2011;26:808–814.CrossRefGoogle ScholarPubMed
DiSaia, P.J. Conservative management of the patient with early gynecologic cancer. CA Cancer J Clin, 1989;39:135–154.CrossRefGoogle ScholarPubMed
Colombo, N, Chiari, S, Maggioni, A et al. Controversial issues in the management of early epithelial ovarian cancer: conservative surgery and role of adjuvant therapy. Gynecol Oncol, 1994;55:S47–S51.Google Scholar
Zanetta, G, Chiari, S, Rota, S et al. Conservative surgery for stage I ovarian carcinoma in women of childbearing age. Br J Obstet Gynaecol, 1997;104:1030–1035.CrossRefGoogle Scholar
Schilder, JM, Thompson, AM, DePriest, PD et al. Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy. Gynecol Oncol, 2002;87:1–7.CrossRefGoogle ScholarPubMed
Morice, P, Leblanc, E, Rey, A et al. GCCLCC and SFOG. Conservative treatment in epithelial ovarian cancer: results of a multicentre study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) and SFOG (Société Francaise d’Oncologie Gynécologique). Hum Reprod, 2005;20:1379–1385.Google Scholar
Park, JY, Kim, DY, Suh, DS et al. Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes. Gynecol Oncol, 2008;110:345–353.CrossRefGoogle ScholarPubMed
Satoh, T, Hatae, M, Watanabe, Y et al. Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection. [Erratum appears in J Clin Oncol 2011 Dec 10;29(35):4725] J of Clini Oncol, 2010;28(10):1727–1732.CrossRefGoogle Scholar
Wright, JD, Shah, M, Mathew, Let al. Fertility preservation in young women with epithelial ovarian cancer. Cancer, 2009;115(18):4118–4126.Google Scholar
Fruscio, R, Corso, S, Ceppi, L et al. Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series. Ann Oncol, 2013 January;24(1):138–144.CrossRefGoogle ScholarPubMed
Fruscio, R, Ceppi, L, Corso, S et al. Long-term results of fertility-sparing treatment compared with standard radical surgery for early-stage epithelial ovarian cancer. Br J Cancer, 2016;115(6):641–648.Google Scholar
Marpeau, O, Schilder, J, Zafrani, Y et al. Prognosis of patients who relapse after fertility-sparing surgery in epithelial ovarian cancer. Ann Surg Oncol, 2008;15:478–483.CrossRefGoogle ScholarPubMed
Bentivegna, E, Fruscio, R, Roussin, S et al. Long-term follow-up of patients with an isolated ovarian recurrence after conservative treatment of epithelial ovarian cancer: review of the results of an international multicenter study comprising 545 patients. Fertil & Steril, 2015;104(5):1319–1324.Google Scholar
Kajiyama, H, Shibata, K, Suzuki, S et al. Is there any possibility of fertility-sparing surgery in patients with clear-cell carcinoma of the ovary? Gynecol Oncol, 2008;111:523–526.CrossRefGoogle ScholarPubMed
Park, JY, Suh, DS, Kim, JH et al. Outcomes of fertility-sparing surgery among young women with FIGO stage I clear cell carcinoma of the ovary. In Gynaecol Obstet, 2016;134(1):49–52.Google Scholar
Petrillo, M, Legge, F, Ferrandina, G et al. Fertility-sparing surgery in ovarian cancer extended beyond the ovaries: a case report and review of the literature. Gynecol Obstet Invest, 2014;77(1):1–5.CrossRefGoogle ScholarPubMed
Kashima, K, Yahata, T, Fujita, K, Tanaka, K. Outcomes of fertility-sparing surgery for women of reproductive age with FIGO stage IC epithelial ovarian cancer. Int J Gynaecol Obstet, 2013;121(1):53–55.Google Scholar
Kwon, YS, Hahn, HS, Kim, TJ et al. Fertility preservation in patients with early epithelial ovarian cancer. J Gynecol Oncol, 2009;20(1):44–47.Google Scholar
Schlaerth, AC, Chi, DS, Poynor, EA, Barakat, RR, Brown, CL. Long-term survival after fertility-sparing surgery for epithelial ovarian cancer. Int J Gynecol Cancer, 2009;19(7):1199–1204.CrossRefGoogle ScholarPubMed
Cheng, X, Cheng, B, Wan, X, Lu, W, Xie, X. Outcomes of conservative surgery in early epithelial ovarian carcinoma. Eur J Gynaecol Oncol, 2012;33(1):93–95.Google Scholar
Peccatori, F, Bonazzi, C, Chiari, S et al. Surgical management of malignant ovarian germ-cell tumors: 10 years’ experience of 129 patients. Obstet Gynecol, 1995;86:367–372.Google Scholar
Mitchell, PL, Al-Nasiri, N, A’Hern, R et al. Treatment of nondysgerminomatous ovarian germ cell tumors: an analysis of 69 cases. Cancer, 1999;85:2232–2244.Google Scholar
Brewer, M, Gershenson, DM, Herzog, CE et al. Outcome and reproductive function after chemotherapy for ovarian dysgerminoma. J Clin Oncol, 1999;17:2670–2675.Google Scholar
Tewari, K, Cappuccini, F, Disaia, PJ et al. Malignant germ cell tumors of the ovary. Obstet Gynecol, 2000;95:128–133.Google Scholar
Low, JJ, Perrin, LC, Crandon, AJ et al. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases. Cancer, 2000;89:391–398.Google Scholar
Zanetta, G, Bonazzi, C, Cantù, M et al. Survival and reproductive function after treatment of malignant germ cell ovarian tumors. J Clin Oncol, 2001;19:1015–1020.Google Scholar
Tangir, J, Zelterman, D, Ma, W et al. Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary. Obstet Gynecol, 2003;101:251–257.Google Scholar
Zanagnolo, V, Sartori, E, Galleri, G et al. Clinical review of 55 cases of malignant ovarian germ cell tumors. Eur J Gynaecol Oncol, 2004;25:315–320.Google Scholar
Boran, N, Tulunay, G, Caliskan, E et al. Pregnancy outcomes and menstrual function after fertility sparing surgery for pure ovarian dysgerminomas. Arch Gynecol Obstet, 2005;271:104–108.Google Scholar
Ayhan, A, Celik, H, Taskiran, C et al. Oncologic and reproductive outcome after fertility-saving surgery in ovarian cancer. Eur J Gynaecol Oncol, 2003;24:223–232.Google Scholar
Kang, H, Kim, TJ, Kim, WY et al. Outcome and reproductive function after cumulative high-dose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor. Gynecol Oncol, 2008;111:106–110.CrossRefGoogle ScholarPubMed
de La Motte Rouge, T, Pautier, P, Duvillard, P et al. Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor. Ann Oncol, 2008;19:1435–1441.CrossRefGoogle ScholarPubMed
Satoh, T, Aoki, Y, Kasamatsu, T et al. Administration of standard-dose BEP regimen (bleomycin+etoposide+cisplatin) is essential for treatment of ovarian yolk sac tumour. Eur J Cancer, 2015 February;51(3):340–351.Google Scholar
Zhang, M, Cheung, MK, Shin, JY et al. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary-an analysis of 376 women. Gynecol Oncol, 2007;104:396–400.Google Scholar
Gouy, S, Arfi, A, Maulard, A et al. Results from a monocentric long-term analysis of 23 patients with an ovarian Sertoli-Leydig cell tumors. The Oncologist, 2019;24(5):702–709.Google Scholar
Colombo, N1, Peiretti, M, Garbi, A et al.; ESMO Guidelines Working Group.Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2012 October;23(Suppl 7):vii20–26.Google Scholar
Schneider, DT, Orbach, D, Cecchetto, G et al. Ovarian Sertoli Leydig cell tumours in children and adolescents: an analysis of the European Cooperative Study Group on Pediatric Rare Tumors (EXPeRT). Eur J Cancer, 2015 March;51(4):543–550.Google Scholar
Zhang, HY, Zhu, JE, Huang, W, Zhu, J. Clinicopathologic features of ovarian Sertoli-Leydig cell tumors. Int J Clin Exp Pathol, 2014 September 15;7(10):6956–6964. eCollection 2014.Google Scholar
Young, RH, Scully, RE. Ovarian Sertoli-Leydig cell tumors. A clinicopathological analysis of 207 cases. Am J Surg Pathol, 1985 August;9(8):543–569. Review.Google Scholar
Schumer, ST, Cannistra, SA. Granulosa cell tumor of the ovary. J Clin Oncol, 2003;21:1180–1189.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×